INS and diabetes mellitus: The United Kingdom Prospective Diabetes Study of 3867 patients with type 2 diabetes found that treatment with sulfonylureas or insulin vs. diet-based treatment significantly reduced the risk of myocardial infarction by 16%, but the effects on stroke, limb amputation or death were not significant [50].